These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 448679)
1. Synthesis, base-catalyzed hydrolytic reactivity, and anticancer evaluation of O-aryl phosphorodiamidates as a novel class of pro(phosphorodiamidic acid mustards). Chiu FT; Tsui FP; Zon G J Med Chem; 1979 Jul; 22(7):802-7. PubMed ID: 448679 [TBL] [Abstract][Full Text] [Related]
2. O-imino esters of N,N-bis(2-chloroethyl)phosphorodiamidic acid. Synthesis, X-ray structure determination, and anticancer evaluation. Ludeman SM; Shao KL; Zon G; Himes VL; Mighell AD; Takagi S; Mizuta K J Med Chem; 1983 Dec; 26(12):1788-90. PubMed ID: 6644750 [TBL] [Abstract][Full Text] [Related]
4. 2',3'-Bis(2-chloroethyl)aminophosphoryl-3'-amino-3'-deoxyadenosine: a cyclic nucleotide with antitumor activity. Okruszek A; Verkade JG J Med Chem; 1979 Jul; 22(7):882-5. PubMed ID: 448687 [TBL] [Abstract][Full Text] [Related]
5. Kinetics of phosphoramide mustard hydrolysis in aqueous solution. Watson E; Dea P; Chan KK J Pharm Sci; 1985 Dec; 74(12):1283-92. PubMed ID: 4087195 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor activity of cyclophosphamide analogues. 4. Preparation, kinetic studies, and anticancer screening of "phenylketophosphamide" and similar compounds related to the cyclophosphamide metabolite aldophosphamide. Ludeman SM; Boyd VL; Regan JB; Gallo KA; Zon G; Ishii K J Med Chem; 1986 May; 29(5):716-27. PubMed ID: 3701785 [TBL] [Abstract][Full Text] [Related]
7. Chemical stability and fate of the cytostatic drug ifosfamide and its N-dechloroethylated metabolites in acidic aqueous solutions. Gilard V; Martino R; Malet-Martino M; Niemeyer U; Pohl J J Med Chem; 1999 Jul; 42(14):2542-60. PubMed ID: 10411475 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, activation, and cytotoxicity of aldophosphamide analogues. Borch RF; Valente RR J Med Chem; 1991 Oct; 34(10):3052-8. PubMed ID: 1920356 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationships of pre-activated analogs of cyclophosphamide (NSC-26271). Montgomery JA; Struck RF Cancer Treat Rep; 1976 Apr; 60(4):381-93. PubMed ID: 945126 [TBL] [Abstract][Full Text] [Related]
10. 31P NMR and chloride ion kinetics of alkylating monoester phosphoramidates. Fries KM; Borch RF J Med Chem; 1991 Feb; 34(2):565-9. PubMed ID: 1995878 [TBL] [Abstract][Full Text] [Related]
11. Protonation of phosphoramide mustard and other phosphoramides. Gamcsik MP; Ludeman SM; Shulman-Roskes EM; McLennan IJ; Colvin ME; Colvin OM J Med Chem; 1993 Nov; 36(23):3636-45. PubMed ID: 8246232 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and antineoplastic activity of a novel series of phosphoramide mustard analogues of pyrimidine deoxyribonucleosides. Lin TS; Fischer PH; Prusoff WH J Med Chem; 1980 Nov; 23(11):1235-7. PubMed ID: 7452673 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of reactive metabolite-analogues of cyclophosphamide for comparisons of NMR kinetic parameters and anticancer screening data. Ludeman SM; Boyd VL; Regan JB; Gallo KA; Zon G; Ishii K Drugs Exp Clin Res; 1986; 12(6-7):527-32. PubMed ID: 3743371 [TBL] [Abstract][Full Text] [Related]
14. Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide. Struck RF; Dykes DJ; Corbett TH; Suling WJ; Trader MW Br J Cancer; 1983 Jan; 47(1):15-26. PubMed ID: 6821629 [TBL] [Abstract][Full Text] [Related]
15. [Synthesis of phosphoramide mustard analogues belonging to the L-sugar series]. Csorvási A; Katalin EK; Sztaricskai F Acta Pharm Hung; 2001 Aug; 71(2):223-6. PubMed ID: 11862674 [TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro. Erickson LC; Ramonas LM; Zaharko DS; Kohn KW Cancer Res; 1980 Nov; 40(11):4216-20. PubMed ID: 7471062 [TBL] [Abstract][Full Text] [Related]
17. An improved synthesis of lysosomal activated mustard prodrug for tumor-specific activation and its cytotoxic evaluation. Adidala R; Devalapally H; Srivari C; Devarakonda R K; Akkinepally RR Drug Dev Ind Pharm; 2012 Sep; 38(9):1047-53. PubMed ID: 22185667 [TBL] [Abstract][Full Text] [Related]
18. Arylzinc alkoxides: [ArZnOCHPr(i)2]2 and Ar2Zn3(OCHPr(i)2)4 when Ar = C6H5, p-CF3C6H4, 2,4,6-Me3C6H2, and C6F5. Chisholm MH; Gallucci JC; Yin H; Zhen H Inorg Chem; 2005 Jun; 44(13):4777-85. PubMed ID: 15962986 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitumor properties of activated cyclophosphamide analogues. Borch RF; Canute GW J Med Chem; 1991 Oct; 34(10):3044-52. PubMed ID: 1920355 [TBL] [Abstract][Full Text] [Related]
20. Aldophosphamide acetal diacetate and structural analogues: synthesis and cytotoxicity studies. Wang YQ; Farquhar D J Med Chem; 1991 Jan; 34(1):197-203. PubMed ID: 1992116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]